Fulvestrant does not stimulate endometrial growth in postmenopausal breast cancer patients

被引：0
|
作者：
Morales, L. [1 ]
Neven, P. [1 ]
Timmerman, D. [1 ]
Wildiers, H. [1 ]
Konstantinovic, M. L. [1 ]
Tan, P. N. [1 ]
Christiaens, M-R [1 ]
Paridaens, R. [1 ]
机构：
[1] Univ Hosp KU Leuven, Fac Med, Louvain, Belgium
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [31] TAMOXIFEN-ASSOCIATED ENDOMETRIAL CARCINOMA IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
    MALFETANO, JH
    GYNECOLOGIC ONCOLOGY, 1990, 39 (01) : 82 - 84
  • [32] Transvaginal ultrasonography and endometrial changes in postmenopausal breast cancer patients receiving tamoxifen
    Dijkhuizen, FPHLJ
    Brolmann, HAM
    Oddens, BJJ
    Roumen, RMH
    Coebergh, JWW
    Heintz, APM
    MATURITAS, 1996, 25 (01) : 45 - 50
  • [33] Ultrasonographic evaluation of endometrial disease in postmenopausal patients with breast cancer and tamoxifen treatment
    Cohen, I
    Tepper, R
    Beyth, Y
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (01) : 252 - 252
  • [34] Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients
    Cohen, I
    Bernheim, J
    Azaria, R
    Tepper, R
    Sharony, R
    Beyth, Y
    GYNECOLOGIC ONCOLOGY, 1999, 75 (01) : 136 - 141
  • [35] Fulvestrant ('Faslodex®') is effective in advanced breast cancer in postmenopausal patients with visceral metastases:: comparison with anastrazole.
    Mauriac, L
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 289 - 289
  • [36] Endometrial damage by antiestrogens in a postmenopausal breast cancer patient
    Ceci, O
    Bettocchi, S
    Marello, F
    Pellegrino, A
    Impedovo, L
    Di Venere, R
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (02) : 174 - 175
  • [37] Fulvestrant in the management of postmenopausal women with advanced, endocrine-responsive breast cancer
    Oakman, Catherine
    Moretti, Erica
    Santarpia, Libero
    Di Leo, Angelo
    FUTURE ONCOLOGY, 2011, 7 (02) : 173 - 186
  • [38] Bone turnover markers in postmenopausal breast cancer treated with fulvestrant - A pilot study
    Agrawal, A.
    Hannon, R. A.
    Cheung, K. L.
    Eastell, R.
    Robertson, J. F. R.
    BREAST, 2009, 18 (03): : 204 - 207
  • [39] Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer
    Samuel, E.
    Chiang, C.
    Jennens, R.
    Faulkner, D.
    Francis, P. A.
    EUROPEAN JOURNAL OF CANCER, 2020, 126 : 104 - 105
  • [40] COMPARISON OF FULVESTRANT VERSUS TAMOXIFEN FOR TREATMENT OF ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN
    Singh, Charu
    Sharma, O. P.
    Sharma, R.
    BREAST, 2013, 22 : S42 - S42
12345